Artemisia capillaris in cosmetics: getting the species right
Artemisia Capillaris Extract is often introduced as “nhân trần”, but in Vietnam the name nhân trần mainly refers to a different plant from another genus. This article clarifies the correct species, the still-limited evidence on skin, Asteraceae allergy considerations and ASEAN regulatory status.
Artemisia capillaris extract (INCI: Artemisia Capillaris Extract) is a solvent extract of Artemisia capillaris Thunb., of the daisy family (Asteraceae). In traditional Chinese medicine this plant is called Yin-Chen (茵陈); Vietnamese herbal references call it “nhân trần cao”, “nhân trần Trung Quốc” (“Chinese nhân trần”) or “nhân trần hao”. In cosmetics, this extract is mainly a botanical ingredient for a skin-soothing story; data on human skin are not yet available.
Note: in Vietnam, “nhân trần” (a Vietnamese herbal name) usually refers to entirely different plants of the genus Adenosma. This article helps you read the name correctly and identify the right species.
1. What is Artemisia capillaris? Why not shorten it to “nhân trần”
According to Đỗ Tất Lợi’s book “Những cây thuốc và vị thuốc Việt Nam” (Medicinal Plants and Remedies of Vietnam), the name nhân trần refers to at least three different plants. Vietnamese nhân trần is Adenosma caeruleum R. Br.; the plant bồ bồ (Adenosma capitatum Benth.) is also purchased under the name nhân trần; the book places both in the figwort family (Scrophulariaceae). According to the same book, Chinese nhân trần (“nhân trần cao”) is Artemisia capillaris Thunb., of the daisy family, with leaves divided into very fine threads, and the author had not seen this plant growing in Vietnam. A herbal medicine website citing the Vietnamese Pharmacopoeia V lists the herbal drug Nhân trần as Herba Adenosmatis caerulei (the stems and branches bearing leaves and flowers of A. caeruleum, plantain family, Plantaginaceae), whereas “nhân trần Bắc” (“northern nhân trần”) and “nhân trần hao” are Artemisia capillaris, of which the aerial parts are used.
| Name | Scientific name, family | Relation to this article’s INCI |
|---|---|---|
| “Nhân trần” (Vietnam) | Adenosma caeruleum R. Br.; figwort or plantain family, depending on the source | Not Artemisia Capillaris Extract |
| “Nhân trần cao”, “nhân trần hao”, Yin-Chen | Artemisia capillaris Thunb.; daisy family | The correct species for this INCI |
| “Ngải cứu” (mugwort) | Artemisia vulgaris L.; daisy family | A different INCI: Artemisia Vulgaris Extract |
Therefore, a product label should use “nhân trần” only together with the scientific name Artemisia capillaris. If the label says only “nhân trần”, Vietnamese consumers will take it to mean the Adenosma plant. The genus Artemisia also includes mugwort (ngải cứu, A. vulgaris), A. annua and A. princeps; each species is a separate INCI, and their data are not interchangeable. See also our article on mugwort in cosmetics (in Vietnamese).
The COSMILE Europe database (accessed November 17, 2026) lists Artemisia Capillaris Extract as a solvent extract, with the plant names “Yin Chen Hao; Fragrant Wormwood; Wormwood”, and its cosmetic function as “not reported”. This page does not state the plant part. Two INCI names with similar wording should be distinguished: Artemisia Capillaris Flower Extract (flower extract, skin conditioning function) and Artemisia Capillaris Leaf Extract (leaf extract).
2. Composition and mechanisms on the skin
A 2021 review (Hsueh et al.) lists the main active compounds of A. capillaris: scoparone, capillarisin, scopoletin and chlorogenic acid, with antioxidant activity and reduction of inflammatory responses in research models. This review focuses mainly on liver disease and the pharmacokinetics of these compounds; these are not topical data.
On skin cells, the studies we reviewed show:
- UVB radiation: in HaCaT human keratinocytes, A. capillaris extract reduced programmed cell death (apoptosis), DNA damage and reactive oxygen species (ROS), and reduced the release of IL-1α, IL-6 and PGE2 after UVB irradiation; the main constituents of the extract were chlorogenic acid and its derivatives (Chen et al., 2024). The authors work for a cosmetics company.
- 5-Lipoxygenase enzyme: a 70% ethanol extract of the aerial parts inhibited leukotriene formation in cells (IC50 < 1.0 µg/mL); from this plant the authors isolated 9 compounds, of which esculetin and quercetin were strong inhibitors (IC50 6.6 and 0.7 µM, respectively). The extract and esculetin reduced arachidonic acid–induced ear edema in mice (Kwon et al., 2011).
- Dermal hyaluronic acid: among 380 plant extracts screened in human fibroblasts, A. capillaris flower extract reduced expression of the HYBID gene (a factor that breaks down hyaluronic acid) and protected high-molecular-weight hyaluronic acid (Biswas et al., 2025). This is a flower extract (INCI Artemisia Capillaris Flower Extract), not this article’s INCI; most of the authors are affiliated with a cosmetic ingredient company.
All of these are cell or animal data and do not demonstrate the effect of a topical product on human skin.
3. Evidence of efficacy: limited
| Study | Test material | Model | Main results (per abstract) |
|---|---|---|---|
| Chen et al., 2024 | A. capillaris extract | UVB-irradiated HaCaT cells | Reduced cell death, DNA damage, ROS, IL-1α, IL-6, PGE2. Industry authors |
| Kwon et al., 2011 | 70% ethanol extract of the aerial parts | Cells; mouse ear edema | Inhibited 5-lipoxygenase; reduced ear edema and delayed-type hypersensitivity in mice |
| Biswas et al., 2025 | A. capillaris flower extract (different INCI) | Cultured human fibroblasts | Reduced HYBID expression, protected high-molecular-weight hyaluronic acid. Industry authors |
Studies applying A. capillaris extract topically in mouse models of atopic dermatitis and psoriasis belong to the context of drug research and are not a basis for cosmetic claims.
A PubMed search (November 17, 2026) for “Artemisia capillaris” combined with terms for skin, cosmetics and human trials found no human skin trial with data for this extract in cosmetic form. Conclusion: limited evidence.
4. Typical concentrations and product formats
We found no safety assessment report by the Cosmetic Ingredient Review (CIR) Expert Panel (US) for Artemisia Capillaris Extract in the sources we were able to search, and no verified public source stating use concentrations in finished products. Therefore, no established concentration exists. In practice:
- Take the use range from the supplier’s technical data sheet, then confirm it with stability studies and tolerance testing on the actual formula.
- Distinguish the extract percentage from the amount of dry matter: liquid extracts contain a carrier solvent (water, glycol), so two raw materials both labeled 1% may contain different amounts of extracted material.
- Commercial raw materials containing Artemisia Capillaris Extract are often sold as complexes with several other botanical extracts and humectants. In that case, each INCI in the complex must be labeled and safety-assessed separately, and the benefits of the other extracts must not be attributed to A. capillaris.
- Formats that suit a botanical story: toner, essence, moisturizer, mask.
5. How to use and combine
- Regard A. capillaris as a “story” ingredient: pair it with ingredients that have better data for moisturizing and soothing, such as glycerin, panthenol and allantoin.
- Do not stack several Asteraceae extracts in one product for sensitive skin, for example A. capillaris (nhân trần hao) together with mugwort or chamomile (in Vietnamese).
- New users should try the product on a small area of skin for a few days before wider use.
6. Safety: who should take care
Asteraceae allergy: we found no contact allergy report specific to A. capillaris on PubMed. However, the plant belongs to the daisy family (Asteraceae). In a study of people already allergic to Asteraceae plants, 8/12 people sensitized to German chamomile (Chamomilla recutita) tested positive to chamomile-containing preparations (tea, cream, ointment, oil), and 5/6 people sensitized to arnica tested positive to arnica-containing products; the authors recommended that people with Asteraceae allergy be warned against using topical products containing Asteraceae plants (Paulsen et al., 2008). This study did not test A. capillaris, but applying the same level of caution is reasonable. See also our article on cosmetic contact dermatitis (in Vietnamese).
Oral data: A. capillaris has been studied mainly as an herbal medicine for liver disease (Hsueh et al., 2021); oral toxicity data do not replace assessment of irritation and sensitization from topical use.
Pregnancy and breastfeeding: there are not enough data for topical use; consult a doctor before use.
7. Perspective for brand owners (B2B)
- ASEAN regulations: we searched for “Artemisia”, “capillaris”, “wormwood”, “Yinchen”, “scoparone”, “capillarisin” and “chlorogenic” in Annexes II, III and VI (version 2026-1, June 22, 2026) and Annex VII (version 2025-2, December 12, 2025): no results. Artemisia Capillaris Extract is not listed in Annexes II/III/VI/VII of these versions.
- Right species, right plant part: the COA should state the scientific name, plant part, solvent, herb-to-extract ratio, microbiological limits and heavy metals. An HPLC study in Korea quantified 10 marker compounds (chlorogenic acid, dicaffeoylquinic acids, scoparone…) and was able to distinguish A. capillaris from Artemisia iwayomogi, a species that may be substituted by mistake in the herbal medicine market (Park et al., 2012); you can therefore ask suppliers for marker-compound specifications.
- Name on the packaging: write “chiết xuất nhân trần hao (Artemisia capillaris)” (Vietnamese for “nhân trần hao extract”), not “nhân trần” alone, to avoid confusion with the Adenosma plant.
- Claims: you may use “soothes the feel of the skin” and “East Asian botanical extract”. Avoid references to acne, atopic dermatitis, psoriasis or “inhibits inflammation”, and do not use liver data from the oral herbal medicine. See also our article on sensitive skin (in Vietnamese) when positioning the product.
Butter-C can use Artemisia capillaris extract in contract manufacturing of toners, essences or moisturizers, with raw materials verified for the correct species and claims kept at the cosmetic level.
Frequently asked questions
Is the “nhân trần” in cosmetics the nhân trần plant commonly used in Vietnam?
Usually not. The nhân trần commonly used in Vietnam refers to plants of the genus Adenosma; the INCI Artemisia Capillaris Extract is the plant Artemisia capillaris of the daisy family, which herbal references call nhân trần cao or nhân trần hao.
Is Artemisia capillaris the same as mugwort (ngải cứu)?
No. The two plants belong to the same genus, Artemisia, but are different species; mugwort is Artemisia vulgaris and has its own INCI.
Does Artemisia capillaris extract help soothe the skin?
There are data from skin cells and mice, but no trials on human skin yet. It should be regarded as a supporting ingredient, paired with soothing ingredients that have better data.
Can people allergic to Asteraceae plants use it?
People with a confirmed allergy to Asteraceae plants should avoid topical products containing Asteraceae plants, as recommended by the study in this patient group, and consult a dermatologist when needed.
Can pregnant women use it?
There are not enough data; consult a doctor before use.
References
- Đỗ Tất Lợi. Nhân Trần (Bồ Bồ) – Những cây thuốc và vị thuốc Việt Nam [Nhân trần (Bồ bồ) – Medicinal Plants and Remedies of Vietnam] (web reprint). Accessed November 17, 2026. https://vnras.com/nhan-tran-bo-bo-nhung-cay-thuoc-va-vi-thuoc-viet-nam-do-tat-loi/
- Trung Tâm Thuốc. Nhân trần (Herba Adenosmatis caerulei) — herbal medicine page citing the Vietnamese Pharmacopoeia V. Accessed November 17, 2026. https://trungtamthuoc.com/duoc-lieu/nhan-tran
- COSMILE Europe. Artemisia Capillaris Extract; compared with Artemisia Capillaris Flower Extract. Accessed November 17, 2026. https://cosmileeurope.eu/inci/detail/18597/artemisia-capillaris-extract/ · https://cosmileeurope.eu/inci/detail/1195/artemisia-capillaris-flower-extract/
- Hsueh TP et al. The Pharmacological Effects and Pharmacokinetics of Active Compounds of Artemisia capillaris. Biomedicines. 2021. PMID 34680529
- Chen Y et al. The protective effect of Artemisia Capillaris Thunb. Extract against UVB-induced apoptosis and inflammation through inhibiting the cGAS/STING pathway. J Photochem Photobiol B. 2024. PMID 39032373
- Kwon OS et al. Inhibition of 5-lipoxygenase and skin inflammation by the aerial parts of Artemisia capillaris and its constituents. Arch Pharm Res. 2011. PMID 21975819
- Biswas KB et al. Artemisia capillaris with two novel active compounds, Kawarayomogin I and II, inhibits HYBID (KIAA1199) expression as well as hyaluronic acid degradation. Sci Rep. 2025. PMID 39820064
- Paulsen E et al. Cosmetics and herbal remedies with Compositae plant extracts - are they tolerated by Compositae-allergic patients? Contact Dermatitis. 2008. PMID 18154553
- Park KM et al. High-performance liquid chromatographic analysis for quantitation of marker compounds of Artemisia capillaris Thunb. Arch Pharm Res. 2012. PMID 23263810
BUTTER-C